1. Home
  2. KOD

as 11-14-2024 9:44am EST

$
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Biological Products (No Diagnostic Substances)

Nasdaq

Kodiak Sciences Inc is a biopharmaceutical company specializing in novel therapeutics to treat high-prevalence retinal diseases. The product candidate of the company is KSI-301, which is a novel antibody biopolymer conjugate, in treatment-naive subjects with neovascular wet AMD.

Founded: 2009 Country:
United States
United States
Employees: N/A City: PALO ALTO
Market Cap: 186.3M IPO Year: 2018
Target Price: $3.25 AVG Volume (30 days): 373.2K
Analyst Decision: Hold Number of Analysts: 5
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: -3.77 EPS Growth: N/A
52 Week Low/High: $1.86 - $7.77 Next Earning Date: 11-19-2024
Revenue: N/A Revenue Growth: N/A
Revenue Growth (this year): N/A Revenue Growth (next year): N/A

KOD Daily Stock ML Predictions

Share on Social Networks: